Michael Charlton to Diacylglycerol O-Acyltransferase
This is a "connection" page, showing publications Michael Charlton has written about Diacylglycerol O-Acyltransferase.
Connection Strength
0.054
-
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study. BMJ Open. 2022 03 30; 12(3):e056159.
Score: 0.054